2.95 USD
▼-0.03-1.01%
盘后 3.54 0.00%
2026-11-20
市值
$69.20M
市盈率
—
EPS
-1.40
股息率
—
52 周区间
2.72 – 6.62
成交量
117.27K
Beta
0.70
目标价
15.21
52W 低 2.7252W 高 6.62
价格走势
公司简介
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. The company develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase 2 trial for use in the treatm...